March 21, 2022
All Resources
Explore our latest resources
Viz.ai Neurovascular Impact Continues to Expand
Our latest blog focuses on the expansion of the neurovascular platforms with articles on the latest data from ISC 2022,...
Mar 15, 2022
Viz.ai Receives FDA 510(k) Clearance for Viz™ ANEURYSM (ANX)
Viz.ai, the world leader in artificial intelligence (AI) powered care coordination, today announced it has received U.S. Food and Drug...
Feb 24, 2022
New Data Presented at ISC 2022 Further Validates Impact of the Viz™ Platform...
Data from several new studies presented this week at the International Stroke Conference (ISC) further validates the best-in-class sensitivity and...
Feb 11, 2022
Viz.ai and TeleSpecialists Announce Strategic Partnership
Viz.ai and TeleSpecialists, LLC have entered a strategic partnership that will bring AI-powered stroke care together with leading telestroke neurologists...
Feb 09, 2022
December 28, 2022
AI for Radiology, on the Proven Viz.ai Platform
AI supported by a proven platform can help radiology teams streamline their workflow and drive better patient outcomes and organizational...
Dec 20, 2021
Viz.ai Debuts Viz™ ANX, the First AI-powered Cerebral Aneurysm Detection Solution at SVIN...
Viz.ai is the leader in AI-powered care coordination and has accelerated the time-to-notification of the treatment team by 73 percent...
Nov 17, 2021
Viz.ai Launches Two New AI-Powered Modules for Pulmonary Embolism and Aortic Disease
Diagnosis and care coordination of patients suffering from pulmonary embolism (PE) can be challenging, with the average arrival-to-treatment times lasting...
Nov 16, 2021